Clinical and Surgical Pearls in Imaging Epilepsy Neil U. Lall1, Justin M. Honce1, Hisham M. Dahmoush2, Eric M. Nyberg1, David M. Mirsky3, Lidia M. Nagae1 1Department of Radiology, University of Colorado, Aurora, CO Radiology, The Children's Hospital of Philadelphia, Philadelphia, PA 3Department of Radiology, Children's Hospital Colorado, Aurora, CO 2Department of ASNR 2015 Annual Meeting eEdE #: eEdE-86a Control #: 511 Disclosures • No Disclosures Educational Objectives/Approach After viewing this exhibit, the learner will: A. Understand the role of imaging in the evaluation and treatment of epilepsy. B. Be familiar with imaging findings of temporal and extratemporal epilepsy. C. Recognize imaging findings related to antiepileptic medications. D. Understand MRI safety issues associated with anti-epileptic implantable devices such as vagal nerve and deep brain stimulators. Epilepsy • Definition = Enduring predisposition to generate seizures. • Affects >4 million people (3% individual lifetime risk). • Substantially decreases quality of life: – Threats to physical safety. – Generation of new epileptogenic foci (may ↑ seizure frequency/duration). – Epileptic encephalopathy or Sudden unexpected death in epilepsy (SUDEP). • Medical treatment fails in 30% of cases. • Surgical management ↓ health care costs and ↑ quality of life. – Success rate is related to the epileptogenic zone. • Epileptogenic Click to DefineZone the Epileptogenic Zone. = Area of cortex indispensable for generation of seizures. Aimed to be completely resected/disconnected for control of seizures. May or may not be identifiable on imaging. Mesial Temporal Sclerosis • Most common form of focal epilepsy, also with the highest surgical success rate. • Coronal oblique images for evaluation of internal architecture of hippocampus (perpendicular to its main axis). • Click to Reveal Findings. Epileptic patient: Hippocampal asymmetry highlights abnormal T2 hyperintense signal, volume loss, and loss of internal architecture. Normal (Non-Epileptic) Patient Epileptic Patient Mesial Temporal Sclerosis Left hippocampal • Primary Findings: Click to Reveal. volume loss, T2 hyperintensity (gliosis), and architectural distortion. Volume loss of ipsilateral • Secondary Findings: Click to Reveal. mammillary body and fornix is common. Coronal Oblique T2 Images Mesial Temporal Sclerosis • • Earlier Stages: Enlarged hippocampus with T2 hyperintense signal. • Ddx: post-ictal changes, low grade glioma, cortical dysplasia, or encephalitis. MRI negative in 20-30%. MRS, PET, or SPECT may provide lateralization. – Best postoperative results with abnormalities on MRI. • 15% “Dual Pathology” = coexistence with other potentially epileptogenic lesions. – Cortical dysplasia, vascular malformation, tumor, injury, neurocysticercosis, microencephalocele. – Controversial cause-effect relationship and surgical approach. • Heterotopic gray matter nodule more posteriorly (same patient as prior slide). Click to Reveal Dual Pathology. Autoimmune Voltage Gated Potassium Channel Encephalitis • • • • Newly described treatable cause of epilepsy, dementia, and psychiatric symptoms. Patients respond to immunotherapy rather than anti-epileptic medications. Unilateral or bilateral enlargement of the amygdala and hippocampus Possible diffusion restriction/mild enhancement. • • Axial T2 FLAIR: mild enlargement and T2 hyperintensity of the right hippocampus. Coronal post-contrast T1: mild post-contrast enhancement of the right hippocampus. Epileptogenic Neoplasms (Gliomas, gangliogliomas, and DNETs) • Surgical resection usually 1st choice of treatment regardless of medical intractability. • Gliomas (astrocytomas, oligodendrogliomas, and oligo-astrocytomas). – Infiltrative, expansile lesions, T2 hyperintense signal. – Enhancement can be seen in higher grade neoplasms. • Gangliogliomas (0.4-7.6% of CNS tumors) highly associated with intractable seizures. Dysembroplastic Neuro Epithelial Tumor • • Benign neoplasm (Rare malignant transformation described in literature). Characteristic imaging findings: – – – Cortically based, wedge-shaped, rare enhancement, T2 bright lesions with minimal mass effect/edema. Calvarial remodeling. “Bubbly appearance” of the lesion with internal septations very suggestive. T2 STIR T2 FLAIR FS T1 Post Contrast Transmantle tumor with indistinct gray-white matter differentiation of associated cortical dysplasia Cerebral Cavernous Malformations • Most common epileptogenic vascular lesions: arteriovenous malformations and cavernous malformations. • No intervening brain parenchyma (as opposed to AVMs). • 4% of the population. • Imaging findings: – – – – Central heterogeneous blood products of various ages and calcification. Minimal edema/mass effect. Usually absent or faint post-contrast enhancement. Classic circumferential hemosiderin (hypointensity on T2, prominent susceptibility on T2*). • Associated developmental venous anomaly in up to 26%. – Surgical preservation to avoid venous infarct. • Complete resection should include epileptogenic hemosiderin rim. – 20-30% have multiple lesions (typically familial): epileptogenic source should be identified to guide surgery. Cerebral Cavernous Malformations • Axial T2* GRE image: Multiple foci of gradient susceptibility corresponding to cavernous malformations. • Axial Click to Reveal Additional Images. restriction from status DWI image: Cortical diffusion epilepticus. Malformations of Cortical Development • Neuroblasts and glioblasts travel along radially oriented glial fibers, “inside-out” from periventricular region cortical plate. • In utero neuronal migrational abnormalities may occur during: – Neuronal–glial proliferation and differentiation. – Neuronal migration to the cortical plate. – Final stages of intracortical organization. • Disorders include: – – – – – Focal cortical dysplasia. Agyria/pachygyria/band heterotopia spectrum. Polymicrogyria. Schizencephaly. Nodular heterotopias. • Subependymal (more common) or subcortical variant. Focal Cortical Dysplasia • • 3rd most common epileptogenic lesion in children (after hippocampal sclerosis and tumors). Findings subtle; Most pronounced in Type IIb (balloon cell) with abnormal white matter signal. – – • • MRI normal in up to 34%. Other findings: mild focal volume loss, gyral simplification, or blurring of gray-white margins. Treatment: Resection of dysplastic area (MRI often does not reveal entire extent). Hyperintense in transmantle pattern from ependyma to cortex (reflecting radially oriented Click to Revealsignal Findings. glial fibers) + indistinct gray-white matter differentiation. Axial T2 FLAIR Agyria/Pachygyria/Band Heterotopia • Spectrum of the related genetic causes (primarily DCx and LIS1). – • • • Agyria (lissencephaly) = Most severe. Smooth hourglass configuration to brain, no sylvian fissures. Pachygyria = simplified gyral pattern (broad gyri with shallow sulci). Band heterotopia = heterotopic band of gray matter between the germinal matrix and the cortex. – • Incomplete migration of superficial layers of cortex. Milder female heterozygous form. Click to Reveal “Double cortexFindings. sign” = Thin band of white matter separating cortex from heterotopic gray matter. Axial T1 Polymicrogyria • Late migrational failure with abnormal development of deep layers of the cerebral cortex. • Possible Etiologies: In utero infections (CMV) and vascular insults. • Associations: Chiari malformation, schizencephaly, numerous syndromes. • Imaging findings: – Innumerable small disorganized gyri, with irregular cortical thickening. – Can be confused with thickened cortex of pachygyria. • Irregular gray-white junction and crowded cortical pattern differentiate polymicrogyria. • Resection may cure epileptogenic unilateral polymicrogyria. Schizencephaly with Polymicrogyria • • • • Polymicrogyria may line schizencephalic cleft or present in a “mirror-image” contralateral location. Closed-lipped Click to Revealschizencephalic Findings. defect (tightly apposed gray matter cleft). Clues:toDimple Click Revealalong Findings. surface of right lateral ventricle, focal enlargement of CSF (at times shows prominent vessel). Click to Reveal Findings. Sagittal demonstrates associated polymicrogyria. Axial T2 FLAIR Coronal T1 Sagittal T1 Nodular Subependymal Heterotopia • • • • • • Single or multiple nodules along ependymal surface of the ventricles (unilateral or bilateral). When diffuse and symmetric, consider underlying genetic cause. Commonresection Surgical associations: of nodules callosaland hypo-/agenesis corresponding and dysplastic ipsilateral cortex basalfor ganglia medically dysmorphia. refractory epilepsy. – Seizure-free outcome of surgery more favorable indysplastic unilateral cases than Surgical resection of nodules and corresponding cortex forbilateral. medically refractory epilepsy Images: Nodularoutcome heterotopic gray more matter lines the bilateralcases lateral ventricles. – Seizure-free of surgery favorable in unilateral than bilateral Images: Common Nodular associations: heterotopic Callosal gray dysgenesis matter lines and the cerebellar bilateralmalformation lateral ventricles. shown below. Click to Reveal Findings. – Click to reveal Additional associations other findings: include ipsilateral basal ganglia dysmorphia. Axial T1 Axial T2 Sagittal T1 Nodular Subcortical Heterotopia • • • Swirling, curvilinear or nodular mass of gray & white matter which may extend from cortex to ventricle. Anomalies such as callosal hypo-/agenesis and ipsilateral basal ganglia dysmorphia commonly associated. Abnormalities/epileptogenic activity extends beyond imaged nodules: – Resection of corresponding dysplastic cortex also required. Coronal T2 STIR Axial T1 non-contrast Neurocutaneous Syndromes • • Congenital abnormalities with common facial stigmata, intellectual disabilities, and seizures. Tuberous Sclerosis – Classic clinical triad of epilepsy, facial angiofibroma (adenoma sebaceum), and mental retardation. – Cortical/subcortical tubers, subependymal nodules, and subependymal giant cell astrocytomas (SEGAs). – Dominant tuber resection can reduce seizure frequency, often improving neuropsychological development. • α-[11C] methyl-L-tryptophan (AMT) PET may identify which of multiple tubers are epileptogenic – Some recently effectively treated with mTOR1 inhibitors such as Everolimus • Sturge-Weber Syndrome – Congenital facial nevus, epilepsy, and ocular abnormalities. – Asymmetric developmental myelination pattern, presumably due to early subclinical seizures. • Affected hemisphere with accelerated myelination low signal on T2WI and high signal on T1WI. – Refractory epilepsy may benefit from hemispherectomy to control seizures and allow neurodevelopment. Tuberous Sclerosis • Conspicuous white matter radial migration lines (T2) – • • • Represent heterotopic neuronal/glial migrational arrest, Tuber often located at associated cortical surface. Tubers poorly identifiable on T2 within background of hyperintense unmyelinated white matter. Tubers and subependymal nodules hyperintense on T1; lesions near foramen of Monro concerning for SEGA. Interval myelination numerous cortical tubers conspicuous. Additionally note prominent Click to Reveal Followmakes Up Images. perivascular spaces. T2 T1 MPRAGE 2 days of age T2 32 months of age Sturge-Weber Syndrome • • CT: Characteristic “tram-track” cortical calcifications MRI (different patient): Hemispheric atrophy and gyriform T1 shortening (from calcification); extensive leptomeningeal enhancement of angioma and enlarged ipsilateral choroid plexus. – Contralateral small leptomeningeal angioma may ↓ success rate of surgery. Noncontrast CT T1 T1 FS Postcontrast Rasmussen’s Encephalitis • Rare but severe progressive unilateral hemispheric atrophy – Associated neuropsychological dysfunction, and intractable seizures. • Though immune-mediated, response to immunotherapy or AED is poor. • Effective treatment: (functional) hemispherectomy or hemispherotomy. – Up to 80% long-term seizure-free outcomes. Neuropsychological decline may be halted. – Significant deficits: Homonymous hemianopsia and hemiplegia (if not present pre-operatively). May regain ability to walk independently. Rasmussen’s Encephalitis • Early signs before hemispheric volume loss is conspicuous: – Ipsilateral ventricular enlargement and volume loss in the basal ganglia and perisylvian region. – FDG-PET and SPECT may show diffuse unilateral hypometabolism or altered perfusion. • • Cortical/subcortical T2 hyperintensity and overlying cortical thinning. Increased Click to Reveal T2 signal Findings. in left insula. Regional volume loss with enlarged Sylvian fissure. Axial T2 FLAIR Coronal T1 Hypothalamic Hamartoma • • • • • Benign congenital malformation of heterotopic mature neurons and glial cells in tuber cinereum Sessile (rather than pedunculated) form commonly with seizures (typically gelastic) Non-enhancing. Calcifications are very rare Seizures typically refractory to medications. Surgical options: Resection or disconnection of the hamartoma, stereotactic thermocoagulation, and gamma knife surgery. Suprasellar mass isointense to gray matter. Click to Reveal Findings. Sagittal T1 MPRAGE Non-Lesional Epilepsy Evaluation • SPECT – Evaluates regional cerebral blood flow in epileptic patients – Both during the ictal period and the interictal period. • Epileptogenic focus: Ictal hyperperfusion and interictal hypoperfusion. • “Subtraction” images often beneficial. – Agents: Tc-99m hexamethyl-propylene amine oxime (HMPAO) and Tc-99m ethyl cysteinate dimer (ECD). • Trapped after 1st pass (in seconds) = Able to assess ictal blood flow. • F-18 fluorodeoxyglucose (FDG) PET – Indirectly measures neuronal function via glucose metabolism. • Epileptogenic focus is hypometabolic in interictal period. – Requires 30-60 minutes for radiotracer uptake and distribution. • Largely restricts utility to interictal evaluation. Ictal and Interictal SPECT • Axial ictal SPECT images fused with MRI in a patient with non-lesional epilepsy. • Click to Reveal Findings. Left frontal cortex: ↑ ictal and concordant mildly ↓ interictal blood flow. Ictal Interictal Interictal PET • Axial PET image fused with MRI in a patient with non-lesional epilepsy. Hypometabolism in right perirolandic cortex suggests epileptogenic focus. • Click to Reveal Findings. Implantable Devices and MRI Safety • Alternatives to resection: Vagal nerve stimulator or deep brain stimulator. – Require transmit/receive head coil: Transmit RF body coils are contraindicated. • Risk of heating injury and/or damage system components in the neck. • Neck, cervical, and thoracic MRI cannot be performed. • However possible to image extremities and lumbar spine with local transmit RF coils. • Patients worked up for surgery may have intracranial monitoring strips/grids/electrodes. – Generally only may image using transmit RF body coil in combination with receive-only surface coil. – Thus incompatible with vagal nerve stimulator or deep brain stimulator. • Low SAR protocols: Refer to manufacturer guidelines to determine field strength compatibility with 3.0T. Imaging Findings on Anti-Epileptic Drugs • Phenytoin: Cerebellar volume loss and calvarial thickening. • Valproate: Encephalopathy and reversible cerebellar volume loss. • Vigabatrin – Irreversible inhibitor of GABA transaminase. – 1st line therapy for infantile spasms. – May cause T2 prolongation and diffusion restriction. • More common in younger infants or on high dose therapy. • Possibly due to intramyelin edema. Vigabatrin Toxicity • Abnormal signal possible in thalami, globus palladi, anterior commissure, dorsal brainstem, corpus callosum, or dentate nuclei. – Most asymptomatic, but extrapyramidal symptoms and acute encephalopathy may develop. • • Click to Reveal Findings. Restricted diffusion of thalami and globus palladi. Discontinuation/reduction usually results in resolution. Click to Reveal Follow Up Imaging. DWI Images - Initial Scan 8 Month Follow Up Treatment-Related MRS Changes • Propan-1,2-diol (1,2-PD) – Vehicle for IV anti-epileptic drugs. – Doublet peak at 1.14 ppm. – Not to be confused with lactate peak (1.33 ppm). • Acetone – Anti-epileptic ketogenic diet. – Singlet peak at 2.22 ppm. – Intraventricular CSF spaces and brain parenchyma. 1,2-PD Acetone PPM 4.0 3.0 2.0 1.0 Lac PPM 4.0 3.0 2.0 1.0 PPM 4.0 3.0 2.0 1.0 Discussion/Summary • There are a wide variety of causes of lesional epilepsy, including mesial temporal sclerosis, neoplasias, cavernous malformations, channelopathies, neurocutaneous syndromes, and malformations of cortical development. • The radiologist’s participation in the clinical and surgical management of patients with epilepsy is key, and familiarity with concepts and approaches is mandatory. • Imaging findings in lesional and non-lesional refractory seizure may impact management. • Vagal nerve stimulators and deep brain stimulators require similar MRI precautions which are generally incompatible with restrictions of intracranial monitoring strips/grids/electrodes. • Anti-epileptic medications may result in varying imaging effects, some on MRI and some on MRS. References • • • • • • • • • • Asenbaum S, Baumgartner C. Nuclear medicine in the preoperative evaluation of epilepsy. Nuclear Medicine Communications. July 2001. 2001:227:835–40. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010:514:676–85. Blümcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011:521:158–74. Castillo, M., Davis, P. C., Takei, Y. & Hoffman, J. C. Intracranial ganglioglioma: MR, CT, and clinical findings in 18 patients. Am. J. Roentgenol. 154, 607–612 (1990). Elger, C. E. & Schmidt, D. Modern management of epilepsy: A practical approach. Epilepsy Behav. 12, 501–539 (2008). Guerrini, R. & Filippi, T. Neuronal migration disorders, genetics, and epileptogenesis. J. Child Neurol. 20, 287–299 (2005). Herron J, Darrah R, Quaghebeur G. IntraCranial Manifestations of the Neurocutaneous Syndromes: Pictorial Review. Clinical Radiology. 2000:552:82–98. Rezai AR, Phillips M, Baker KB, et al. Neurostimulation System Used for Deep Brain Stimulation (DBS): MR Safety Issues and Implications of Failing to Follow Safety Recommendations. Investigative Radiology. May 2004. 2004:395:300–303. Salanova, V., Markand, O. & Worth, R. Temporal lobe epilepsy: analysis of patients with dual pathology. Acta Neurol. Scand. 109, 126–131 (2004). Zentner, J. et al. Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients. J. Neurol. Neurosurg. Psychiatry 57, 1497–1502 (1994).